Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2722612 | 0.82 | ALDH1A1 (0.47) | ALOX15LMNABLMPMP22ALDH1A1 | |
| SCHEMBL27559300 | 0.79 | — | — | |
| SCHEMBL673909 | 0.75 | — | — | |
| SCHEMBL1697441 | 0.75 | — | — | |
| SCHEMBL11987205 | 0.74 | — | — | |
| SCHEMBL13932571 | 0.74 | — | — | |
| SCHEMBL31028520 | 0.72 | ALDH1A1 (0.44) | ALOX15LMNABLMPMP22ALDH1A1 | |
| SCHEMBL28448859 | 0.72 | ALDH1A1 (0.44) | ALOX15LMNABLMPMP22ALDH1A1 | |
| SCHEMBL21782553 | 0.71 | — | — | |
| Acetic Acid SCHEMBL28864537 | 0.69 | FFAR3 (0.50) | LMNAALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383653-B2 | Neutral multidomain peptide hydrogels and uses thereof | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383653-B2 | Neutral multidomain peptide hydrogels and uses thereof | MYADM, FIBP, LNPEP | ALOX15 3814/4885LMNA 2025/4885BLM 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.